Literature DB >> 32769171

Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease.

Christian F Krebs1,2, Daniel Reimers3, Yu Zhao4, Hans-Joachim Paust5, Patricia Bartsch5, Sarah Nuñez6, Mariana V Rosemblatt7, Malte Hellmig5, Christoph Kilian5, Alina Borchers5, Leon U B Enk5, Michael Zinke5, Martina Becker8, Joanna Schmid3, Stefanie Klinge3, Milagros N Wong8, Victor G Puelles8,9, Constantin Schmidt3, Tabea Bertram3, Natascha Stumpf10, Elion Hoxha8, Catherine Meyer-Schwesinger11, Maja T Lindenmeyer8, Clemens D Cohen8,12, Michael Rink13, Christian Kurts10, Sören Franzenburg14, Friedrich Koch-Nolte2,3, Jan-Eric Turner2,8, Jan-Hendrik Riedel5, Samuel Huber2,15, Nicola Gagliani2,15,16, Tobias B Huber2,8, Thorsten Wiech7, Holger Rohde17, Maria Rosa Bono18, Stefan Bonn2,4,19,20, Ulf Panzer5,2, Hans-Willi Mittrücker21,3.   

Abstract

Although it is well established that microbial infections predispose to autoimmune diseases, the underlying mechanisms remain poorly understood. After infection, tissue-resident memory T (TRM) cells persist in peripheral organs and provide immune protection against reinfection. However, whether TRM cells participate in responses unrelated to the primary infection, such as autoimmune inflammation, is unknown. By using high-dimensional single-cell analysis, we identified CD4+ TRM cells with a TH17 signature (termed TRM17 cells) in kidneys of patients with ANCA-associated glomerulonephritis. Experimental models demonstrated that renal TRM17 cells were induced by pathogens infecting the kidney, such as Staphylococcus aureus, Candida albicans, and uropathogenic Escherichia coli, and persisted after the clearance of infections. Upon induction of experimental glomerulonephritis, these kidney TRM17 cells rapidly responded to local proinflammatory cytokines by producing IL-17A and thereby exacerbate renal pathology. Thus, our data show that pathogen-induced TRM17 cells have a previously unrecognized function in aggravating autoimmune disease.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32769171     DOI: 10.1126/sciimmunol.aba4163

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  20 in total

Review 1.  Tissue-resident memory T cells in the urogenital tract.

Authors:  Loreto Parga-Vidal; Michiel C van Aalderen; Regina Stark; Klaas P J M van Gisbergen
Journal:  Nat Rev Nephrol       Date:  2022-01-25       Impact factor: 28.314

2.  IL-17 Receptor C Signaling Controls CD4+ TH17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases.

Authors:  Tilman Schmidt; Jonas Luebbe; Christoph Kilian; Jan-Hendrik Riedel; Sonja Hiekmann; Nariaki Asada; Pauline Ginsberg; Lennart Robben; Ning Song; Anna Kaffke; Anett Peters; Alina Borchers; Richard A Flavell; Nicola Gagliani; Penelope Pelzcar; Samuel Huber; Tobias B Huber; Jan-Eric Turner; Hans-Joachim Paust; Christian F Krebs; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2021-12       Impact factor: 10.121

3.  Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Authors:  Liang Li; Wei Tang; Yan Zhang; Meng Jia; Limei Wang; Quanxin Li; Qingsheng Han; Xiuping Peng; Yusheng Xie; Jichao Wu; Ziying Wang; Junhui Zhen; Xiaojie Wang; Min Liu; Yu Sun; Chun Zhang; Fan Yi
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

Review 4.  Targeting immune cell metabolism in kidney diseases.

Authors:  Paulo José Basso; Vinicius Andrade-Oliveira; Niels Olsen Saraiva Câmara
Journal:  Nat Rev Nephrol       Date:  2021-04-07       Impact factor: 28.314

Review 5.  Cytokine-regulated Th17 plasticity in human health and diseases.

Authors:  Silvia Cerboni; Ulf Gehrmann; Silvia Preite; Suman Mitra
Journal:  Immunology       Date:  2020-11-06       Impact factor: 7.397

6.  Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection.

Authors:  Patricia Bartsch; Christoph Kilian; Malte Hellmig; Hans-Joachim Paust; Alina Borchers; Amirrtavarshni Sivayoganathan; Leon Enk; Yu Zhao; Nikhat Shaikh; Henning Büttner; Milagros N Wong; Victor G Puelles; Thorsten Wiech; Richard Flavell; Tobias B Huber; Jan-Eric Turner; Stefan Bonn; Samuel Huber; Nicola Gagliani; Hans-Willi Mittrücker; Holger Rohde; Ulf Panzer; Christian F Krebs
Journal:  PLoS Pathog       Date:  2022-04-21       Impact factor: 6.823

Review 7.  A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis.

Authors:  Upendra Rathore; Darpan Radheshyam Thakare; Pallavi Patro; Vikas Agarwal; Aman Sharma; Durga Prasanna Misra
Journal:  Clin Rheumatol       Date:  2021-11-03       Impact factor: 3.650

8.  The m6A reader IMP2 directs autoimmune inflammation through an IL-17- and TNFα-dependent C/EBP transcription factor axis.

Authors:  Rami Bechara; Nilesh Amatya; Rachel D Bailey; Yang Li; Felix E Y Aggor; De-Dong Li; Chetan V Jawale; Bianca M Coleman; Ning Dai; Nandan S Gokhale; Tiffany C Taylor; Stacy M Horner; Amanda C Poholek; Anita Bansal; Partha S Biswas; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2021-07-02

9.  Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.

Authors:  Yu Zhao; Christoph Kilian; Jan-Eric Turner; Lidia Bosurgi; Kevin Roedl; Patricia Bartsch; Ann-Christin Gnirck; Filippo Cortesi; Christoph Schultheiß; Malte Hellmig; Leon U B Enk; Fabian Hausmann; Alina Borchers; Milagros N Wong; Hans-Joachim Paust; Francesco Siracusa; Nicola Scheibel; Marissa Herrmann; Elisa Rosati; Petra Bacher; Dominik Kylies; Dominik Jarczak; Marc Lütgehetmann; Susanne Pfefferle; Stefan Steurer; Julian Schulze Zur-Wiesch; Victor G Puelles; Jan-Peter Sperhake; Marylyn M Addo; Ansgar W Lohse; Mascha Binder; Samuel Huber; Tobias B Huber; Stefan Kluge; Stefan Bonn; Ulf Panzer; Nicola Gagliani; Christian F Krebs
Journal:  Sci Immunol       Date:  2021-02-23

10.  Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis.

Authors:  Christian F Krebs; Jan-Eric Turner; Jan-Hendrik Riedel; Ulf Panzer
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.